封面
市場調查報告書
商品編碼
2064960

基因編輯作物市場預測至 2034 年:按作物類型、性狀類型、技術、應用、最終用戶和地區進行全球分析。

Gene-Edited Crops Market Forecasts to 2034 - Global Analysis By Crop Type (Cereals & Grains, Fruits & Vegetables, Oilseeds, Pulses & Legumes and Other Crop Types), Trait Type, Technology, Application, End User and Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據,預計到 2026 年,全球基因編輯作物市場規模將達到 68 億美元,並在預測期內以 16.8% 的複合年成長率成長,到 2034 年將達到 235 億美元。

基因改造作物是指利用CRISPR-Cas等先進基因組編輯技術,對其遺傳物質進行精確改造,從而在不引入外源DNA的情況下改良其性狀的植物。這些作物的研發目標是在提高產量、增強抗病性、耐旱性和營養價值的同時,減少對化學肥料和農藥的依賴。與傳統育種方法相比,基因編輯技術能夠實現更快、更精準的改良。基因改造作物被視為未來糧食安全和氣候適應農業的關鍵創新。監管部門日益成長的認可度和生物技術的進步正在推動全球範圍內基因改造作物的研究、開發和商業化進程。

糧食安全面臨的壓力日益增大

隨著人口成長,對高產量、抗逆性強的作物需求日益成長。基因編輯技術能夠精準地改造作物,進而提高產量和營養價值。世界各國政府都在支持研發舉措,以加強糧食價值鏈。農業技術公司也正在投資CRISPR及相關工具,以加速作物研發。農民也逐漸認知到基因編輯品種的益處,並且對它們的認知度正在不斷提高。

法規核准的複雜性

各國標準不一阻礙了全球推廣。冗長的核准流程抑制了對新品種的投資。中小企業難以滿足複雜的合規要求。公眾的質疑也是法規核准的一大障礙。各國政府在平衡創新與安全問題方面也持謹慎態度。

CRISPR技術的進步

CRISPR技術能夠實現精準、經濟、快速的作物基因編輯。農民正受益於產量提升、抗蟲害能力增強以及對氣候變遷的適應性增強。製造商正在開發基於CRISPR技術的解決方案,以適應各種作物的需​​求。世界各國政府都在資助相關項目,加速CRISPR技術在農業領域的應用。生技公司與研究機構之間的合作正在拓展其應用範圍。這些技術進步正在推動基因編輯作物市場的快速成長。

智慧財產糾紛

相互競爭的專利給開發商和農民帶來了不確定性。法律糾紛會延緩新品種作物的商業化。中小企業難以支付專有技術的授權費用。智慧財產權執法方面的區域差異使全球業務擴張更加複雜。供應商在確保跨司法管轄區合規方面面臨挑戰。這些糾紛阻礙了市場的持續成長。

新型冠狀病毒(COVID-19)的影響:

新冠疫情對基因編輯作物市場產生了複雜的影響。一方面,隨著疫情期間糧食安全成為首要任務,需求增加。研究機構加快了抗性作物的研發計畫。線上平台也促進了生物技術知識和工具的傳播。另一方面,供應鏈中斷延緩了田間試驗和核准程序。經濟的不確定性限制了對生物技術基礎設施的投資。整體而言,疫情起到了催化劑的作用,提高了人們對基因編輯作物的認知,並促進了其長期應用。

在預測期內,糧食細分市場預計將佔據最大的市場佔有率。

預計在預測期內,穀物領域將佔據最大的市場佔有率。這是因為這些主糧作物對全球糧食安全至關重要,並將從基因編輯技術的創新中受益最多。小麥、稻米和玉米的商業農場正逐步採用基因編輯技術。生產商正在投資研發更耐寒、產量更高的基因編輯品種。各國政府透過補貼和先導計畫支持創新。宣傳宣傳活動正在強調穀物的營養價值。基因編輯穀物在全球零售市場的滲透率正在不斷提高。

預計在預測期內,生物製藥應用領域將呈現最高的複合年成長率。

在預測期內,生物製藥應用領域預計將呈現最高的成長率,這主要得益於基因編輯作物(可作為治療性蛋白質和疫苗的生物工廠)需求的不斷成長。研究人員正在探索將作物作為一種經濟高效的藥物生產平台。宣傳宣傳活動強調了生物技術農業在醫療保健領域的作用。各國政府正資助相關舉措,以加速生物製藥創新。生物技術公司與製藥公司之間的合作正在擴大其影響力。新創企業正迅速將基因編輯技術應用於醫療領域。

市佔率最大的地區:

在預測期內,北美預計將佔據最大的市場佔有率,這得益於其先進的生物技術基礎設施、強大的投資能力以及對基因編輯技術的早期應用。美國和加拿大是農業生物技術領域領先創新者的聚集地。政策框架鼓勵永續的、生物技術主導的農業實踐。私人企業正擴大採用高品質的基因編輯作物。生物技術解決方案在零售市場的滲透在全部區域十分廣泛。學術機構正在積極研究CRISPR技術的應用。

複合年成長率最高的地區:

在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於各國政府對生物技術農業舉措的補貼支持。中國、印度和日本等國正大力投資基因編輯研究。價格適中的解決方案正受到中小型農戶的青睞。農村數位化計畫正在擴大生物技術技術的普及範圍。電子商務平台正在助力基因編輯種子向偏遠地區分銷。年輕一代對永續生物技術解決方案的興趣日益濃厚。

免費客製化服務:

所有購買此報告的客戶均可享受以下免費自訂選項之一:

  • 企業概況
    • 對其他市場參與者(最多 3 家公司)進行全面分析
    • 對主要公司進行SWOT分析(最多3家公司)
  • 區域細分
    • 應客戶要求,我們提供主要國家的市場估算和預測,以及複合年成長率(註:需進行可行性檢查)。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章:研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章:競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球基因編輯作物市場:依作物類型分類

  • 穀類和穀類食品
  • 水果和蔬菜
  • 油籽
  • 豆科植物
  • 其他作物類型

第6章 全球基因編輯作物市場:依性狀類型分類

  • 抗病性狀
  • 抗蟲性狀
  • 耐旱性和氣候變遷耐受性狀
  • 營養增強性狀
  • 其他特徵類型

第7章 全球基因編輯作物市場:依技術分類

  • CRISPR-Cas系統
  • TALEN技術
  • ZFN技術
  • 其他技術

第8章 全球基因編輯作物市場:依應用領域分類

  • 商業農業
  • 研究與開發
  • 種子開發公司
  • 生物製藥應用
  • 其他用途

第9章 全球基因編輯作物市場:依最終用戶分類

  • 農業企業
  • 種子生產商
  • 研究機構
  • 政府農業機構
  • 其他最終用戶

第10章 全球基因編輯作物市場:依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區(RoW)
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章:公司簡介

  • Bayer Crop Science
  • Corteva Agriscience
  • Syngenta AG
  • Pairwise Plants
  • Editas Medicine
  • Calyxt Inc.
  • Inari Agriculture
  • CRISPR Therapeutics
  • Beam Therapeutics
  • Precigen Inc.
  • Benson Hill Inc.
  • Tropic Biosciences
  • KeyGene NV
  • Yield10 Bioscience
  • Sangamo Therapeutics
Product Code: SMRC36938

According to Stratistics MRC, the Global Gene-Edited Crops Market is accounted for $6.8 billion in 2026 and is expected to reach $23.5 billion by 2034 growing at a CAGR of 16.8% during the forecast period. Gene-edited crops are plants whose genetic material has been precisely modified using advanced genome editing technologies such as CRISPR-Cas systems to improve traits without introducing foreign DNA. These crops are developed to enhance yield, disease resistance, drought tolerance, and nutritional content while reducing reliance on chemical inputs. Gene editing offers faster and more targeted improvements compared to traditional breeding methods. These crops are considered a key innovation for future food security and climate-resilient agriculture. Increasing regulatory acceptance and biotechnology advancements are driving research and commercialization of gene-edited crops worldwide.

Market Dynamics:

Driver:

Increasing food security pressure

Rising populations are creating demand for higher-yield and resilient crops. Gene-editing technologies allow precise modifications to improve productivity and nutritional value. Governments are supporting research initiatives to strengthen food supply chains. Agritech firms are investing in CRISPR and related tools to accelerate crop development. Awareness among farmers is growing as they recognize the benefits of gene-edited varieties.

Restraint:

Regulatory approval complexities

Different countries enforce varying standards, slowing global adoption. Lengthy approval processes discourage investment in new varieties. Smaller firms struggle to navigate complex compliance requirements. Public skepticism adds further challenges to regulatory acceptance. Governments are cautious about balancing innovation with safety concerns.

Opportunity:

CRISPR technology advancements

CRISPR enables precise, cost-effective, and rapid crop modifications. Farmers benefit from improved yields, pest resistance, and climate resilience. Manufacturers are developing CRISPR-based solutions tailored to diverse crops. Governments are funding projects to accelerate CRISPR adoption in agriculture. Partnerships between biotech firms and research institutions are expanding reach. This technological progress is fostering rapid growth in the gene-edited crops market.

Threat:

Intellectual property disputes

Competing patents create uncertainty for developers and farmers. Legal battles can delay commercialization of new crop varieties. Smaller firms struggle to afford licensing fees for proprietary technologies. Regional differences in IP enforcement complicate global expansion. Vendors face challenges in ensuring compliance across jurisdictions. These disputes are constraining consistent market growth.

Covid-19 Impact:

Covid-19 had a mixed impact on the gene-edited crops market. On one hand, demand rose as food security became a priority during the pandemic. Research institutions accelerated projects to develop resilient crops. Online platforms supported distribution of biotech knowledge and tools. On the other hand, supply chain disruptions delayed field trials and approvals. Economic uncertainty limited investments in biotech infrastructure. Overall, the pandemic acted as a catalyst, boosting awareness and long-term adoption.

The cereals & grains segment is expected to be the largest during the forecast period

The cereals & grains segment is expected to account for the largest market share during the forecast period as these staple crops are critical for global food security and benefit most from gene-editing innovations. Adoption is strong among commercial farms producing wheat, rice, and maize. Manufacturers are investing in durable and high-yield gene-edited varieties. Governments are supporting innovation through subsidies and pilot projects. Awareness campaigns highlight the importance of cereals in nutrition. Retail penetration of gene-edited cereals is expanding across global markets.

The biopharmaceutical applications segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the biopharmaceutical applications segment is predicted to witness the highest growth rate due to rising demand for gene-edited crops that serve as biofactories for therapeutic proteins and vaccines. Researchers are exploring crops as cost-effective platforms for drug production. Awareness campaigns emphasize the role of biotech agriculture in healthcare. Governments are funding initiatives to accelerate biopharmaceutical innovation. Partnerships between biotech firms and pharmaceutical companies are expanding reach. Startups are rapidly adopting gene-editing for medical applications.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share owing to advanced biotech infrastructure, strong investment capacity, and early adoption of gene-editing technologies. The US and Canada host leading innovators in agricultural biotechnology. Policy frameworks encourage sustainable and biotech-driven farming practices. Commercial enterprises are increasingly deploying premium gene-edited crops. Retail penetration of biotech solutions is widespread across the region. Academic institutions are actively researching CRISPR applications.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by supportive government subsidies for biotech farming initiatives. Countries such as China, India, and Japan are investing heavily in gene-editing research. Affordable solutions are gaining traction among mid-sized farms. Rural digitization programs are expanding access to biotech technologies. E-commerce platforms are helping distribute gene-edited seeds to remote areas. Younger demographics are increasingly drawn to sustainable biotech solutions.

Key players in the market

Some of the key players in Gene-Edited Crops Market include Bayer Crop Science, Corteva Agriscience, Syngenta AG, Pairwise Plants, Editas Medicine, Calyxt Inc., Inari Agriculture, CRISPR Therapeutics, Beam Therapeutics, Precigen Inc., Benson Hill Inc., Tropic Biosciences, KeyGene N.V., Yield10 Bioscience and Sangamo Therapeutics.

Key Developments:

In March 2026, Corteva Agriscience announced a comprehensive commercial biologicals update ahead of the Cereals 2026 exhibition at Diddly Squat Farm, highlighting the rapid market expansion of its BlueN(TM) and Utrisha(R) N biostimulants. This product rollout utilizes specialized nitrogen-fixing bacteria to colonize the plant's internal microbiome, enabling crops to capture atmospheric nitrogen continuously and boosting overall resource use efficiency by up to 40 percent.

In June 2025, Syngenta AG finalized the comprehensive integration of Novartis' Strains and Natural Products Collection, a massive repository of genetic strains and natural compounds engineered for agricultural microbiome optimization. This asset acquisition significantly accelerates Syngenta's biologicals pipeline, complementing the production capacity of its newly opened 22,000-square-meter biostimulant manufacturing facility in Orangeburg, South Carolina, which is purpose-built to deliver 16,000 tons of bio-based inputs annually.

Microbe Types Covered:

  • Bacteria-Based Products
  • Fungi-Based Products
  • Virus-Based Biocontrol Agents
  • Protozoa & Others
  • Other Microbe Types

Applications Covered:

  • Soil Health Management
  • Crop Protection
  • Nutrient Enhancement
  • Yield Improvement
  • Other Applications

Formulations Covered:

  • Liquid Formulations
  • Solid / Powder Formulations
  • Granular Formulations
  • Seed Coatings
  • Other Formulations

Crop Types Covered:

  • Cereals & Grains
  • Fruits & Vegetables
  • Pulses & Oilseeds
  • Plantation Crops
  • Other Crop Types

Distribution Channels Covered:

  • Direct Sales
  • Agri Input Retailers
  • E-Commerce Platforms
  • Cooperatives & Institutions
  • Other Distribution Channels

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Gene-Edited Crops Market, By Crop Type

  • 5.1 Cereals & Grains
  • 5.2 Fruits & Vegetables
  • 5.3 Oilseeds
  • 5.4 Pulses & Legumes
  • 5.5 Other Crop Types

6 Global Gene-Edited Crops Market, By Trait Type

  • 6.1 Disease Resistance Traits
  • 6.2 Pest Resistance Traits
  • 6.3 Drought & Climate Resilience Traits
  • 6.4 Nutritional Enhancement Traits
  • 6.5 Other Trait Types

7 Global Gene-Edited Crops Market, By Technology

  • 7.1 CRISPR-Cas Systems
  • 7.2 TALEN Technology
  • 7.3 ZFN Technology
  • 7.4 Other Technologies

8 Global Gene-Edited Crops Market, By Application

  • 8.1 Commercial Agriculture
  • 8.2 Research & Development
  • 8.3 Seed Development Companies
  • 8.4 Biopharmaceutical Applications
  • 8.5 Other Applications

9 Global Gene-Edited Crops Market, By End User

  • 9.1 Agriculture Companies
  • 9.2 Seed Producers
  • 9.3 Research Institutes
  • 9.4 Government Agricultural Bodies
  • 9.5 Other End Users

10 Global Gene-Edited Crops Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 Bayer Crop Science
  • 13.2 Corteva Agriscience
  • 13.3 Syngenta AG
  • 13.4 Pairwise Plants
  • 13.5 Editas Medicine
  • 13.6 Calyxt Inc.
  • 13.7 Inari Agriculture
  • 13.8 CRISPR Therapeutics
  • 13.9 Beam Therapeutics
  • 13.10 Precigen Inc.
  • 13.11 Benson Hill Inc.
  • 13.12 Tropic Biosciences
  • 13.13 KeyGene N.V.
  • 13.14 Yield10 Bioscience
  • 13.15 Sangamo Therapeutics

List of Tables

  • Table 1 Global Gene-Edited Crops Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Gene-Edited Crops Market, By Crop Type (2023-2034) ($MN)
  • Table 3 Global Gene-Edited Crops Market, By Cereals & Grains (2023-2034) ($MN)
  • Table 4 Global Gene-Edited Crops Market, By Fruits & Vegetables (2023-2034) ($MN)
  • Table 5 Global Gene-Edited Crops Market, By Oilseeds (2023-2034) ($MN)
  • Table 6 Global Gene-Edited Crops Market, By Pulses & Legumes (2023-2034) ($MN)
  • Table 7 Global Gene-Edited Crops Market, By Other Crop Types (2023-2034) ($MN)
  • Table 8 Global Gene-Edited Crops Market, By Trait Type (2023-2034) ($MN)
  • Table 9 Global Gene-Edited Crops Market, By Disease Resistance Traits (2023-2034) ($MN)
  • Table 10 Global Gene-Edited Crops Market, By Pest Resistance Traits (2023-2034) ($MN)
  • Table 11 Global Gene-Edited Crops Market, By Drought & Climate Resilience Traits (2023-2034) ($MN)
  • Table 12 Global Gene-Edited Crops Market, By Nutritional Enhancement Traits (2023-2034) ($MN)
  • Table 13 Global Gene-Edited Crops Market, By Other Trait Types (2023-2034) ($MN)
  • Table 14 Global Gene-Edited Crops Market, By Technology (2023-2034) ($MN)
  • Table 15 Global Gene-Edited Crops Market, By CRISPR-Cas Systems (2023-2034) ($MN)
  • Table 16 Global Gene-Edited Crops Market, By TALEN Technology (2023-2034) ($MN)
  • Table 17 Global Gene-Edited Crops Market, By ZFN Technology (2023-2034) ($MN)
  • Table 18 Global Gene-Edited Crops Market, By Other Technologies (2023-2034) ($MN)
  • Table 19 Global Gene-Edited Crops Market, By Application (2023-2034) ($MN)
  • Table 20 Global Gene-Edited Crops Market, By Commercial Agriculture (2023-2034) ($MN)
  • Table 21 Global Gene-Edited Crops Market, By Research & Development (2023-2034) ($MN)
  • Table 22 Global Gene-Edited Crops Market, By Seed Development Companies (2023-2034) ($MN)
  • Table 23 Global Gene-Edited Crops Market, By Biopharmaceutical Applications (2023-2034) ($MN)
  • Table 24 Global Gene-Edited Crops Market, By Other Applications (2023-2034) ($MN)
  • Table 25 Global Gene-Edited Crops Market, By End User (2023-2034) ($MN)
  • Table 26 Global Gene-Edited Crops Market, By Agriculture Companies (2023-2034) ($MN)
  • Table 27 Global Gene-Edited Crops Market, By Seed Producers (2023-2034) ($MN)
  • Table 28 Global Gene-Edited Crops Market, By Research Institutes (2023-2034) ($MN)
  • Table 29 Global Gene-Edited Crops Market, By Government Agricultural Bodies (2023-2034) ($MN)
  • Table 30 Global Gene-Edited Crops Market, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.